JOP20180126A1 - عمليات جديدة من أجل تحضير منشطات محلقة غوانيلات قابلة للذوبان - Google Patents
عمليات جديدة من أجل تحضير منشطات محلقة غوانيلات قابلة للذوبانInfo
- Publication number
- JOP20180126A1 JOP20180126A1 JOP/2018/0126A JOP20180126A JOP20180126A1 JO P20180126 A1 JOP20180126 A1 JO P20180126A1 JO P20180126 A JOP20180126 A JO P20180126A JO P20180126 A1 JOP20180126 A1 JO P20180126A1
- Authority
- JO
- Jordan
- Prior art keywords
- compound
- preparation
- guanylate cyclase
- soluble guanylate
- novel processes
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C209/00—Preparation of compounds containing amino groups bound to a carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C231/00—Preparation of carboxylic acid amides
- C07C231/12—Preparation of carboxylic acid amides by reactions not involving the formation of carboxamide groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C231/00—Preparation of carboxylic acid amides
- C07C231/14—Preparation of carboxylic acid amides by formation of carboxamide groups together with reactions not involving the carboxamide groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C235/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
- C07C235/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton
- C07C235/04—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton being acyclic and saturated
- C07C235/06—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton being acyclic and saturated having the nitrogen atoms of the carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
- C07C237/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton
- C07C237/04—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being acyclic and saturated
- C07C237/06—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being acyclic and saturated having the nitrogen atoms of the carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D261/00—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
- C07D261/02—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings
- C07D261/06—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members
- C07D261/08—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D261/00—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
- C07D261/02—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings
- C07D261/06—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members
- C07D261/10—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D261/18—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
- C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
- C07D263/30—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D263/34—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Enzymes And Modification Thereof (AREA)
Abstract
يتعلق الكشف الحالي بالعمليات الجديدة لتحضير مركبات مفيدة كمحفزات من إنزيم حلقي جوانيلات قابل للذوبان (sGC). تكون هذه العمليات قابلة للتعديل لعملية تحضير واسعة النطاق وإنتاج مركبات 3-(2-بيريميدينيل) بيرازول مستقرة وفقا للصيغة I، بما في ذلك مركب I، مركب IA ومركب IB، بنقاء ونتائج عالية. يكون للاختراع الحالي الميزة الإضافية لظروف تفاعل سهلة، قابلة للتعديل لزيادة التصنيع واسع النطاق. يقدم الكشف أيضا مركبات وسيطة جديدة مفيدة في تحضير المركبات المفيدة. الصيغة I مركب I مركب IA مركب IB
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201662359430P | 2016-07-07 | 2016-07-07 | |
PCT/US2017/040817 WO2018009602A2 (en) | 2016-07-07 | 2017-07-06 | Novel processes for preparation of soluble guanylate cyclase stimulators |
Publications (1)
Publication Number | Publication Date |
---|---|
JOP20180126A1 true JOP20180126A1 (ar) | 2019-01-30 |
Family
ID=59351140
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JOP/2018/0126A JOP20180126A1 (ar) | 2016-07-07 | 2018-12-24 | عمليات جديدة من أجل تحضير منشطات محلقة غوانيلات قابلة للذوبان |
Country Status (17)
Country | Link |
---|---|
US (2) | US11834444B2 (ar) |
EP (1) | EP3481821B1 (ar) |
JP (1) | JP7054395B2 (ar) |
KR (1) | KR102513357B1 (ar) |
CN (1) | CN109563086B (ar) |
AU (1) | AU2017292811B2 (ar) |
BR (1) | BR112019000292A2 (ar) |
CA (1) | CA3029376A1 (ar) |
CL (1) | CL2019000017A1 (ar) |
EA (1) | EA201990236A1 (ar) |
ES (1) | ES2962829T3 (ar) |
IL (1) | IL263994B (ar) |
JO (1) | JOP20180126A1 (ar) |
MA (1) | MA45593A (ar) |
MX (1) | MX2019000138A (ar) |
SG (2) | SG11201900125PA (ar) |
WO (1) | WO2018009602A2 (ar) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR102487872B1 (ko) | 2016-07-07 | 2023-01-12 | 사이클리온 테라퓨틱스, 인크. | 가용성 구아닐레이트 시클라제 자극제의 신규 제조 방법 |
WO2019161534A1 (en) * | 2018-02-22 | 2019-08-29 | Ironwood Pharmaceuticals, Inc. | Novel processes and intermediates for preparation of soluble guanylate cyclase stimulators |
KR20200106920A (ko) | 2018-01-10 | 2020-09-15 | 사이클리온 테라퓨틱스, 인크. | 가용성 구아닐레이트 시클라제 자극제의 제조를 위한 신규 방법 및 중간체 |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101955439A (zh) * | 2009-07-14 | 2011-01-26 | 华东理工大学 | 一种α-取代-2-氨基乙酰胺的拆分方法 |
CN107021951B (zh) | 2010-06-30 | 2020-10-20 | 赛克里翁治疗有限公司 | sGC刺激物 |
JP5715710B2 (ja) * | 2011-01-13 | 2015-05-13 | ノバルティス アーゲー | 新規複素環誘導体および神経障害の処置におけるそれらの使用 |
CA2861804C (en) | 2011-12-27 | 2021-10-26 | Ironwood Pharmaceuticals, Inc. | 2-benzyl,3(pyrimidin-2-yl)substituted pyrazoles useful as sgc stimulators |
HUE059178T2 (hu) | 2013-03-15 | 2022-10-28 | Cyclerion Therapeutics Inc | SGC stimulátorok |
WO2016044447A1 (en) * | 2014-09-17 | 2016-03-24 | Ironwood Pharmaceuticals, Inc. | Pyrazole derivatives as sgc stimulators |
AU2016364976B2 (en) * | 2015-11-30 | 2022-08-25 | Cyclerion Therapeutics, Inc. | Solid dispersions comprising a sGC stimulator |
US10889577B2 (en) | 2016-07-07 | 2021-01-12 | Cyclerion Therapeutics, Inc. | Solid forms of an sGC stimulator |
KR102487872B1 (ko) | 2016-07-07 | 2023-01-12 | 사이클리온 테라퓨틱스, 인크. | 가용성 구아닐레이트 시클라제 자극제의 신규 제조 방법 |
-
2017
- 2017-07-06 JP JP2019500469A patent/JP7054395B2/ja active Active
- 2017-07-06 CN CN201780048199.7A patent/CN109563086B/zh active Active
- 2017-07-06 SG SG11201900125PA patent/SG11201900125PA/en unknown
- 2017-07-06 MA MA045593A patent/MA45593A/fr unknown
- 2017-07-06 BR BR112019000292-8A patent/BR112019000292A2/pt active Search and Examination
- 2017-07-06 ES ES17740238T patent/ES2962829T3/es active Active
- 2017-07-06 AU AU2017292811A patent/AU2017292811B2/en active Active
- 2017-07-06 SG SG10202100168XA patent/SG10202100168XA/en unknown
- 2017-07-06 EA EA201990236A patent/EA201990236A1/ru unknown
- 2017-07-06 WO PCT/US2017/040817 patent/WO2018009602A2/en unknown
- 2017-07-06 CA CA3029376A patent/CA3029376A1/en active Pending
- 2017-07-06 EP EP17740238.5A patent/EP3481821B1/en active Active
- 2017-07-06 US US16/315,221 patent/US11834444B2/en active Active
- 2017-07-06 MX MX2019000138A patent/MX2019000138A/es unknown
- 2017-07-06 KR KR1020197003461A patent/KR102513357B1/ko active IP Right Grant
-
2018
- 2018-12-24 JO JOP/2018/0126A patent/JOP20180126A1/ar unknown
- 2018-12-27 IL IL263994A patent/IL263994B/en unknown
-
2019
- 2019-01-04 CL CL2019000017A patent/CL2019000017A1/es unknown
-
2023
- 2023-10-30 US US18/385,025 patent/US20240199595A1/en active Pending
Also Published As
Publication number | Publication date |
---|---|
JP2019524712A (ja) | 2019-09-05 |
EP3481821C0 (en) | 2023-09-06 |
IL263994B (en) | 2021-10-31 |
EA201990236A1 (ru) | 2019-08-30 |
EP3481821A2 (en) | 2019-05-15 |
EP3481821B1 (en) | 2023-09-06 |
ES2962829T3 (es) | 2024-03-21 |
JP7054395B2 (ja) | 2022-04-13 |
US20210284632A1 (en) | 2021-09-16 |
AU2017292811A1 (en) | 2019-02-07 |
CL2019000017A1 (es) | 2019-05-03 |
CA3029376A1 (en) | 2018-01-11 |
WO2018009602A2 (en) | 2018-01-11 |
WO2018009602A3 (en) | 2018-03-15 |
AU2017292811B2 (en) | 2021-10-21 |
CN109563086B (zh) | 2023-05-23 |
US11834444B2 (en) | 2023-12-05 |
SG10202100168XA (en) | 2021-02-25 |
US20240199595A1 (en) | 2024-06-20 |
IL263994A (en) | 2019-01-31 |
KR102513357B1 (ko) | 2023-03-24 |
SG11201900125PA (en) | 2019-02-27 |
MX2019000138A (es) | 2019-06-10 |
MA45593A (fr) | 2019-05-15 |
CN109563086A (zh) | 2019-04-02 |
BR112019000292A2 (pt) | 2019-04-16 |
KR20190025987A (ko) | 2019-03-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX2022001495A (es) | Procesos novedosos para preparar estimuladores de guanilato ciclasa soluble. | |
MX2023000044A (es) | Nuevos procesos e intermediarios para la preparacion de estimulantes de guanilato ciclasa soluble. | |
PH12017501413A1 (en) | Substituted nucleoside derivatives useful as anticancer agents | |
MY172391A (en) | Processes for preparing dihydropyrimidine derivatives and intermediates thereof | |
MX350892B (es) | Síntesis de compuesto antiviral. | |
NZ600119A (en) | Process and intermediates for the preparation of 5-biphenyl-4-yl-2-methylpentanoic acid derivatives | |
JOP20180126A1 (ar) | عمليات جديدة من أجل تحضير منشطات محلقة غوانيلات قابلة للذوبان | |
PH12019502865A1 (en) | Method for preparing intermediate of 4-methoxypyrrole derivative | |
MX2018014130A (es) | Procedimiento e intermedios para la 6,7-alfa-epoxidacion de 4,6-dienos esteroideos. | |
MX2018014128A (es) | 6.7.beta-epoxidos esteroideos como intermedios quimicos. | |
MX362102B (es) | Método para producir 4-[5-(piridin-4-il)-1h-1,2,4-triazol-3-il]pir idina-2-carbonitrilo e intermediario del mismo. | |
PH12018500151A1 (en) | Compound targeting il-23a and b-cell activating factor (baff) and uses thereof | |
MX2017017022A (es) | Metodo para la sintesis de derivados de rapamicina. | |
PH12019502638A1 (en) | Method for preparing intermediate of 4-methoxypyrrole derivative | |
SG10201901578UA (en) | Processes for the preparation of pyrimidinylcyclopentane compounds | |
MX2021002896A (es) | Proceso para preparar 1-(3,5-diclorofenil)-2,2,2-trifluoroetanona y sus derivados. | |
MX2013004193A (es) | Procedimiento para la preparacion de derivados de acido 3-(6-amino-piridin-3-il)-2-acrilico. | |
MX349740B (es) | Proceso para la preparacion de fenilpropanonas sustituidas. | |
EA202091664A1 (ru) | Новые способы и промежуточные соединения для получения стимуляторов растворимой гуанилатциклазы | |
MX2017009839A (es) | Proceso para la produccion de derivados de imidazolo condensados. | |
MX2017010192A (es) | Proceso de produccion de ciclo-deshidrolinalool (i). | |
UA123716U (uk) | Обетіхолева кислота | |
IN2013CH04373A (ar) |